Active Ingredient: CEFEPIME HYDROCHLORIDE; ENMETAZOBACTAM
Proprietary Name: EXBLIFEP
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: EQ 2GM BASE/VIAL;0.5GM/VIAL
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N216165
Product Number: 001
Approval Date: Feb 22, 2024
Applicant Holder Full Name: ALLECRA THERAPEUTICS SAS
Marketing Status:
Discontinued
Patent and Exclusivity Information
